WST Surges 167 in Volume to Rank 485th Yet Slides 0.21 Amid Regional Exposure Concerns

On August 28, 2025, West (WST) recorded a trading volume of $0.19 billion, marking a 167.06% surge from the previous day and ranking 485th among active stocks. The stock closed down 0.21% for the session.

West Pharmaceutical Services, Inc. specializes in manufacturing containment and delivery systems for injectable drugs, including syringe components, cartridge systems, and auto-injection devices. Its revenue breakdown shows 81.3% from self-manufactured products and 18.7% from contract manufacturing. Geographically, the U.S. accounts for 42% of sales, followed by Germany (13.8%), Ireland (9.7%), France (9.6%), and other European markets (13.1%).

The company’s exposure to regional markets and product diversification may influence its stock performance. With a significant portion of revenue tied to the U.S., macroeconomic shifts or regulatory changes in key therapeutic areas could impact demand for its drug containment solutions.

Query limit exceeded.